Related Experiment Video
Updated: Dec 6, 2025

The Soft Agar Colony Formation Assay
Published on: October 27, 2014
MicroRNA-708 targeting ZNF549 regulates colon adenocarcinoma development through PI3K/AKt pathway
1Shanghai Eighth People's Hospital, Shanghai, 200235, China.
Abstract:
Colon adenocarcinoma (COAD) is the most common type of gastrointestinal cancer and is still the third leading cause of cancer-related mortality worldwide. Therefore, finding new and promising drugs to eradicate cancer may be a feasible method to treat COAD patients. Cys2-His2 zinc finger proteins (ZFPs) is one of the largest transcription factor family and many of them are highly involved in regulation of cell differentiation, proliferation, apoptosis, and neoplastic transformation. In this study, we identified a tumor-inhibiting factor, ZNF549, which expressed lowly in COAD tissues and COAD cell lines (HT29, HCT116, SW480, LoVo, and SW620). Overexpression of ZNF549 inhibit the ability of COAD cell proliferation and migration. On the contrary, decreasing the ZNF549 expression level promote the ability of COAD cell proliferation and migration. Through bioinformatics analysis, we found that ZNF549 was a potential target of hsa-miR-708-5p (miR-708-5p). Furthermore, we verified the possibility of miR-708-5p targeting the ZNF549 gene, and miR-708-5p inhibited the expression of ZNF549 by luciferase reporter assays, qRT-PCR and western blot assays. Moreover, the relationship between miR-708-5p and phosphatidylinositol 3-kinase/AKt (PI3K/AKt) signal pathway was elucidated. Overexpression and inhibition of miR-708-5p resulted in increased and decreased expression of p-AKt and p-PI3K in HCT116 cells, respectively. RT-qPCR and western blot assays results demonstrated that miR-708-5p regulated COAD cells development by promoting the process of Epithelial-mesenchymal transition (EMT) through PI3K/AKt signaling pathway. In summary, our findings demonstrated that ZNF549, the target gene of miR-708-5p, functions as a tumor suppressor to inhibit COAD cell lines proliferation and migration through regulate the PI3K/AKt signal pathway.
Insights
ZNF549 acts as a tumor suppressor in colon adenocarcinoma (COAD) by inhibiting cell proliferation and migration. It is targeted by miR-708-5p, which promotes COAD development via the PI3K/Akt pathway.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Colon adenocarcinoma (COAD) is a leading cause of cancer mortality.
- Cys2-His2 zinc finger proteins (ZFPs) regulate crucial cellular processes including proliferation and apoptosis.
- Identifying novel therapeutic targets for COAD is critical.
Purpose of the Study:
- To identify and characterize novel tumor-inhibiting factors in COAD.
- To investigate the role of ZNF549 and its regulation by miR-708-5p in COAD.
- To elucidate the molecular mechanisms underlying ZNF549 and miR-708-5p in COAD progression.
Main Methods:
- Bioinformatics analysis to identify potential targets.
- Gene expression analysis (qRT-PCR, Western blot) in COAD tissues and cell lines.
- Functional assays (proliferation, migration) upon ZNF549 or miR-708-5p manipulation.
- Luciferase reporter assays to confirm gene targeting.
- Analysis of the PI3K/Akt signaling pathway.
Main Results:
- ZNF549 expression is significantly downregulated in COAD tissues and cell lines.
- Overexpression of ZNF549 inhibits COAD cell proliferation and migration, while its knockdown promotes these processes.
- miR-708-5p directly targets ZNF549, inhibiting its expression.
- miR-708-5p promotes COAD cell proliferation and migration by activating the PI3K/Akt pathway and inducing Epithelial-mesenchymal transition (EMT).
Conclusions:
- ZNF549 functions as a tumor suppressor in COAD.
- The miR-708-5p/ZNF549 axis plays a critical role in COAD progression.
- Targeting the miR-708-5p/ZNF549/PI3K/Akt pathway may offer a therapeutic strategy for COAD.
More Related Videos
09:45An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells
Published on: May 21, 2019
13:18Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
Published on: March 3, 2023
Related Concept Videos
MicroRNAs
MicroRNAs
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
Abnormal Proliferation